Cytori Therapeutics is a global leader in regenerative medicine.
In the US, Cytori has developed technology to assist the physician in reconstructive and aesthetic surgery procedures. Our key technology is the Celution® 700 system that prepares an autologous tissue graft for delivery back to the patient in the same surgical procedure. This innovative technology is under review by the US Food and Drug Administration but is not available today in the US.
Internationally, Cytori’s technology is commercially available today in many countries in Europe and Asia through our offices in Japan and Italy, or our global distribution partners. In addition, Cytori is currently investigating the use of our technology for many indications beyond reconstructive and aesthetic surgery. Please link to the international website for information on Cytori’s technology that is available to help patients around the world.
